Stock listing
CHRS Stock Price, News, Filings & Events — Coherus Oncology, Inc.
Selected listing: CHRS · NASDAQ · USD · US
This page tracks Coherus Oncology, Inc.'s CHRS:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CHRS:NASDAQ. CHRS:NASDAQ is the stock-level entry point for investors researching Coherus Oncology, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Coherus Oncology, Inc. is a public company traded on the American stock market under the ticker CHRS. The company has a market capitalization of approximately $217.5 million. Coherus focuses on developing innovative therapies for cancer treatment.
- Ticker
- CHRS:NASDAQ
- Asset type
- Stock
- Market cap
- $219.4M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Coherus Oncology, Inc. CHRS:NASDAQ stock context
This page tracks Coherus Oncology, Inc.'s CHRS:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CHRS:NASDAQ. CHRS:NASDAQ is the stock-level entry point for investors researching Coherus Oncology, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Coherus Oncology, Inc. is a public company traded on the American stock market under the ticker CHRS. The company has a market capitalization of approximately $217.5 million. Coherus focuses on developing innovative therapies for cancer treatment.
Latest news from Coherus Oncology, Inc.
Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights
August 17, 2026
Coherus Oncology Reports Second Quarter 2026 Financial Results and Provides Business Update
August 5, 2026
Coherus Oncology to Report Second Quarter 2026 Financial Results on August 5, 2026
July 22, 2026
Coherus and Zumutor Biologics Announce Clinical Collaboration to Evaluate ZM008 in Combination with LOQTORZI® (toripalimab-tpzi)
June 23, 2026
Coherus Oncology Reports First Quarter 2026 Financial Results and Provides Business Update
May 11, 2026
Coherus Oncology, Inc. earnings calls
Coherus Oncology, Inc. (CHRS) Q2 2026 Earnings Call
August 5, 2026 · Replay with transcript and chapters
Coherus Oncology, Inc. (CHRS) Q1 2026 Earnings Call
May 11, 2026 · Replay with transcript and chapters
Coherus Oncology, Inc. (CHRS) Q4 2025 Earnings Call
March 9, 2026 · Replay with transcript and chapters
Coherus Oncology, Inc. (CHRS) Q3 2025 Earnings Call
November 6, 2025 · Replay with transcript and chapters
Coherus Oncology, Inc. (CHRS) Q2 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
Coherus Oncology, Inc. (CHRS) Q1 2025 Earnings Call
May 12, 2025 · Replay with transcript and chapters
Research Coherus Oncology, Inc.
Coherus Oncology, Inc. investor report
Review AI stock analysis and investor report context for CHRS:NASDAQ.
Coherus Oncology, Inc. company profile
View the public company page for Coherus Oncology, Inc. on 6ix.
Coherus Oncology, Inc. news
Read company news and market updates connected to Coherus Oncology, Inc..
Coherus Oncology, Inc. investor events
Find investor webinars, events, and replay context for Coherus Oncology, Inc..
Alternate listings
8C5:TRADEGATE
DE · EUR
Alternate listing for Coherus Oncology, Inc.; the primary context on this page is CHRS:NASDAQ.
8C5:GETTEX
DE · EUR
Alternate listing for Coherus Oncology, Inc.; the primary context on this page is CHRS:NASDAQ.
A12ETZ:LS
DE · EUR
Alternate listing for Coherus Oncology, Inc.; the primary context on this page is CHRS:NASDAQ.
A12ETZ:LSX
DE · EUR
Alternate listing for Coherus Oncology, Inc.; the primary context on this page is CHRS:NASDAQ.
CHRS:BOATS
US · USD
Alternate listing for Coherus Oncology, Inc.; the primary context on this page is CHRS:NASDAQ.
8C5:BX
CH · CHF
Alternate listing for Coherus Oncology, Inc.; the primary context on this page is CHRS:NASDAQ.
8C5:DUS
DE · EUR
Alternate listing for Coherus Oncology, Inc.; the primary context on this page is CHRS:NASDAQ.
8C5:FWB
DE · EUR
Alternate listing for Coherus Oncology, Inc.; the primary context on this page is CHRS:NASDAQ.
8C5:MUN
DE · EUR
Alternate listing for Coherus Oncology, Inc.; the primary context on this page is CHRS:NASDAQ.
8C5:SWB
DE · EUR
Alternate listing for Coherus Oncology, Inc.; the primary context on this page is CHRS:NASDAQ.